Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Phu-Quoc Le, MD PhD, Beatrice Gulbis, MD PhD, Laurence Dedeken, MD, Laurence Rozen, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Fleur Samantha Benghiat, Andre Efira, MD, Marie-Françoise Dresse, MD PhD, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2018-99-119319

Published: 2018

Journal Articles

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Phu-Quoc Lê, MD, Alina Ferster, MD, Laurence Dedeken, MD, Laurence Rozen, PharmD, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Sophie Huybrechts, MD, Christine Devalck, MD, Catherine Heijmans, MD, Marie-Françoise Dresse, MD PhD, André Efira, MD, Samantha Benghiat, MD PhD, Sophie Dupont, MD, Beatrice Gulbis, MD PhD

Blood (2014) 124 (21): 4935.

https://doi.org/10.1182/blood.V124.21.4935.4935

Published: 2014

Journal Articles

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Phu-Quoc Lê, MD, Laurence Dedeken, MD, Beatrice Gulbis, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Sophie Huybrechts, MD, Samantha Benghiat, MD, André Efira, MD, Marie-Francoise Dresse, MD, Sophie Dupont, MD, Alina Ferster, MD

Blood (2013) 122 (21): 2231.

https://doi.org/10.1182/blood.V122.21.2231.2231

Published: 2013

Journal Articles

Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling

Franco Locatelli, Nabil Kabbara, Annalisa Ruggeri, Ardeshir Ghavamzadeh, Irene Roberts, Chi Kong Li, Françoise Bernaudin, Christiane Vermylen, Jean-Hugues Dalle, Jerry Stein, Robert Wynn, Catherine Cordonnier, Fernando Pinto, Emanuele Angelucci, Gérard Socié, Eliane Gluckman, Mark C. Walters, Vanderson Rocha

Blood (2013) 122 (6): 1072–1078.

https://doi.org/10.1182/blood-2013-03-489112

Published: 2013

Includes: Supplemental data

Journal Articles

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

Phu-Quoc Le, MD, Beatrice Gulbis, MD, PhD, Laurence Dedeken, MD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christiane Vermylen, MD, PhD, Sophie Huybrechts, MD, Christine Devalck, MD, Frederic Cotton, PhD, Ba Cuong Nguyen, Françoise Vertongen, MD, PhD, Malou Ngalula, Alina Ferster, MD

Blood (2012) 120 (21): 4757.

https://doi.org/10.1182/blood.V120.21.4757.4757

Published: 2012

Journal Articles

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Blood (2012) 120 (21): 135.

https://doi.org/10.1182/blood.V120.21.135.135

Published: 2012

Journal Articles

Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study

Blood (2012) 119 (12): 2935–2942.

https://doi.org/10.1182/blood-2011-04-349688

Published: 2012

Journal Articles

Excellent Prognosis of Late Relapses of ETV6/RUNX1 Childhood Acute Lymphoblastic Leukemia: Lessons From the FRALLE 93 Protocol

Virginie Gandemer, MD, PhD, Sylvie Chevret, Arnaud Petit, Christiane Vermylen, MD, PhD, Thierry Leblanc, MD, Gerard Michel, Claudine Schmitt, Odile Lejars, Jean-Pierre Vannier, Francois Demeocq, Brigitte Bader-Meunier, Francoise Bernaudin, Yves Perel, MD, PhD, Marie-Francoise Auclerc, Jean Michel Cayuela, MD, PhD, Guy Leverger, MD, PhD, Andre Baruchel

Blood (2011) 118 (21): 1508.

https://doi.org/10.1182/blood.V118.21.1508.1508

Published: 2011

Journal Articles

Possible Dose Adjustment of Hydroxyurea In Young Patients with Sickle Cell Disease and Followed In the Belgian Registry

Phu-Quoc Le, MD, Beatrice Gulbis, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Françoise Vertongen, MD, PhD, Alina Ferster, MD

Blood (2010) 116 (21): 4823.

https://doi.org/10.1182/blood.V116.21.4823.4823

Published: 2010

Journal Articles

Efficiency of the Neonatal Screening Program for Sickle Cell Disease. the Belgian Experience

Phu-Quoc Le, MD, Alina Ferster, MD, Françoise Vertongen, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Ba-Cuong Nguyen, Malou Ngalula Mijinga, nurse, Beatrice Gulbis, MD, PhD

Blood (2010) 116 (21): 4816.

https://doi.org/10.1182/blood.V116.21.4816.4816

Published: 2010

Journal Articles

National Clinical Data Base for Sickle Cell Disease In Belgium

Phu-Quoc Lê, MD, Alina Ferster, MD, Françoise Vertongen, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, André Efira, MD, Ba-Cuong Nguyen, Malou Ngalula Mujinga, nurse, Beatrice Gulbis, MD, PhD

Blood (2010) 116 (21): 2659.

https://doi.org/10.1182/blood.V116.21.2659.2659

Published: 2010

Journal Articles

Excellent Prognosis of Children with ETV6-RUNX1 Positive (+) Acute Lymphoblastic Leukemia (ALL) in the FRALLE 2000 Protocol.

Virginie Gandemer, MD, Marie-Françoise Auclerc, MD, Arnaud Petit, MD, Benoît Brethon, MD, Paola Ballerini, Gerard Michel, MD, PhD, Yves Perel, MD, PhD, Anne Auvrignon, MD, Francoise Mechinaud, Claudine Schmitt, Pascale Schneider, Christiane Vermylen, Odile Lejars, MD, Thierry Leblanc, MD, Jean Gabert, MD, PhD, Elizabeth Macintyre, MD, PhD, Jean-Michel Cayuela, PharmD, PhD, Guy Leverger, MD, Andre Baruchel, MD

Blood (2009) 114 (22): 1628.

https://doi.org/10.1182/blood.V114.22.1628.1628

Published: 2009

Journal Articles

Pediatric Sibling Donor Complications of Hematopoietic Stem Cell Collection: EBMT Pediatric Diseases Working Party Study.

Blood (2009) 114 (22): 806.

https://doi.org/10.1182/blood.V114.22.806.806

Published: 2009

Journal Articles

High-Dose Methotrexate Seems to Benefit Only to Standard-Risk BCP-ALL Patients with Good Early Response to Chemotherapy: Final Analysis of the FRALLE93B Study

Blood (2008) 112 (11): 10.

https://doi.org/10.1182/blood.V112.11.10.10

Published: 2008

Journal Articles

Rituximab Therapy for Autoimmune Hemolytic Anemia and Immune Thrombocytopenia: A Belgian Registry.

Daan Dierickx, MD, Philippe Mineur, MD, Agnes Triffet, MD, Alain Kentos, MD, Carine Keppens, MD, Pascal Pierre, MD, Alina Ferster, MD, Dominique Boulet, MD, Christiane Vermylen, MD, Bernard Deprijk, MD, Yves Beghin, MD, Marie-France Dresse, MD, Khalil Kargar, MD, Greet Bries, MD, Gregor Verhoef, MD, Andre Delannoy, MD

Blood (2007) 110 (11): 1737.

https://doi.org/10.1182/blood.V110.11.1737.1737

Published: 2007

Journal Articles

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia

Blood (2006) 107 (9): 3455–3462.

https://doi.org/10.1182/blood-2005-08-3430

Published: 2006

Journal Articles

A Plateau after 30 Months of Follow-Up in B -Lineage Childhood Acute Lymphoblastic Leukemia (ALL) with t(1;19)(q23;p13)/E2A-PBX1?.

André Baruchel, MD, Sylvie Chevret, MD, PhD, Anne Auvrignon, MD, Paola Ballerini, MD, PhD, Gérard Michel, MD, Jean Gabert, MD, PhD, Christiane Vermylen, MD, Yves Perel, MD, Chrystèle Bilhou-Nabera, MD, Odile Lejars, MD, Claudine Schmitt, MD, Pierre Jonveaux, MD, PhD, Jean Soulier, MD, PhD, Jacqueline Vandenaker, MD, Marie-Françoise Auclerc, MD, Thierry Leblanc, MD, Guy Leverger, MD, for the FRALLE Group

Blood (2005) 106 (11): 1441.

https://doi.org/10.1182/blood.V106.11.1441.1441

Published: 2005

Journal Articles

Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience

Béatrice Gulbis, David Haberman, Dominique Dufour, Catherine Christophe, Christiane Vermylen, Faustin Kagambega, Francis Corazza, Christine Devalck, Marie-Françoise Dresse, Kathleen Hunninck, Axel Klein, Phu Quoc Le, Michèle Loop, Philip Maes, Pierre Philippet, Eric Sariban, Chris Van Geet, Alina Ferster

Blood (2005) 105 (7): 2685–2690.

https://doi.org/10.1182/blood-2004-07-2704

Published: 2005

Journal Articles

Minimal Residual Disease (MRD) at the End of Induction (EOI) after a Three or Four-Drug Induction Regimen for Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Interim Results of the FRALLE 2000-A Protocol.

Blood (2004) 104 (11): 1105.

https://doi.org/10.1182/blood.V104.11.1105.1105

Published: 2004

Journal Articles

Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Toxicity and Efficacy Interim Results of the FRALLE 2000-A Protocol.

Blood (2004) 104 (11): 1952.

https://doi.org/10.1182/blood.V104.11.1952.1952

Published: 2004

NARROW

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study

Excellent Prognosis of Late Relapses of ETV6/RUNX1 Childhood Acute Lymphoblastic Leukemia: Lessons From the FRALLE 93 Protocol

Possible Dose Adjustment of Hydroxyurea In Young Patients with Sickle Cell Disease and Followed In the Belgian Registry

Efficiency of the Neonatal Screening Program for Sickle Cell Disease. the Belgian Experience

National Clinical Data Base for Sickle Cell Disease In Belgium

Excellent Prognosis of Children with ETV6-RUNX1 Positive (+) Acute Lymphoblastic Leukemia (ALL) in the FRALLE 2000 Protocol.

Pediatric Sibling Donor Complications of Hematopoietic Stem Cell Collection: EBMT Pediatric Diseases Working Party Study.

High-Dose Methotrexate Seems to Benefit Only to Standard-Risk BCP-ALL Patients with Good Early Response to Chemotherapy: Final Analysis of the FRALLE93B Study

Rituximab Therapy for Autoimmune Hemolytic Anemia and Immune Thrombocytopenia: A Belgian Registry.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia

A Plateau after 30 Months of Follow-Up in B -Lineage Childhood Acute Lymphoblastic Leukemia (ALL) with t(1;19)(q23;p13)/E2A-PBX1?.

Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience

Minimal Residual Disease (MRD) at the End of Induction (EOI) after a Three or Four-Drug Induction Regimen for Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Interim Results of the FRALLE 2000-A Protocol.

Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Toxicity and Efficacy Interim Results of the FRALLE 2000-A Protocol.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only